Focused Wealth Management, Inc Pfizer Inc Transaction History

Focused Wealth Management, Inc

$746 Million
Q3 2024

A detailed history of Focused Wealth Management, Inc transactions in Pfizer Inc stock. As of the latest transaction made, Focused Wealth Management, Inc holds 104,696 shares of PFE stock, worth $2.8 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

104,696

Previous 105,304 0.58%

Holding current value

$2.8 Million

Previous $2.95 Million 2.82%

% of portfolio

0.41%

Previous 0.42%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$27.7 - $31.39 $16,841 - $19,085	-608 Reduced 0.58%	104,696 $3.03 Million
Q2 2024 Jul 30, 2024	SELL	$25.26 - $29.6 $337,953 - $396,018	-13,379 Reduced 11.27%	105,304 $2.95 Million
Q1 2024 May 08, 2024	SELL	$25.89 - $29.73 $389,696 - $447,495	-15,052 Reduced 11.26%	118,683 $3.29 Million
Q4 2023 Jan 10, 2024	BUY	$26.13 - $33.94 $867,097 - $1.13 Million	33,184 Added 33.0%	133,735 $3.85 Million
Q3 2023 Nov 01, 2023	BUY	$32.09 - $37.51 $320,547 - $374,687	9,989 Added 11.03%	100,551 $3.34 Million
Q2 2023 Aug 08, 2023	BUY	$36.12 - $41.79 $560,546 - $648,539	15,519 Added 20.68%	90,562 $3.32 Million
Q1 2023 Apr 13, 2023	SELL	$39.39 - $51.28 $101,626 - $132,302	-2,580 Reduced 3.32%	75,043 $3.06 Million
Q4 2022 Jan 13, 2023	BUY	$41.75 - $54.5 $25,133 - $32,809	602 Added 0.78%	77,623 $0
Q3 2022 Oct 20, 2022	SELL	$43.76 - $53.42 $854,501 - $1.04 Million	-19,527 Reduced 20.23%	77,021 $3.37 Million
Q2 2022 Aug 04, 2022	SELL	$46.53 - $55.17 $244,654 - $290,083	-5,258 Reduced 5.16%	96,548 $5.06 Million
Q1 2022 Apr 29, 2022	SELL	$45.75 - $56.69 $114,924 - $142,405	-2,512 Reduced 2.41%	101,806 $5.27 Million
Q4 2021 Jan 31, 2022	BUY	$41.32 - $61.25 $74,830 - $110,923	1,811 Added 1.77%	104,318 $6.16 Million
Q3 2021 Oct 12, 2021	BUY	$39.25 - $50.42 $45,883 - $58,940	1,169 Added 1.15%	102,507 $4.41 Million
Q2 2021 Jul 15, 2021	BUY	$35.91 - $40.68 $46,216 - $52,355	1,287 Added 1.29%	101,338 $3.97 Million
Q1 2021 May 03, 2021	BUY	$33.49 - $37.77 $600,140 - $676,838	17,920 Added 21.82%	100,051 $3.63 Million
Q4 2020 Feb 03, 2021	BUY	$33.47 - $42.56 $460,714 - $585,838	13,765 Added 20.13%	82,131 $3.02 Million
Q3 2020 Oct 19, 2020	SELL	$31.75 - $37.25 $22,256 - $26,112	-701 Reduced 1.01%	68,366 $2.51 Million
Q2 2020 Jul 24, 2020	BUY	$30.12 - $36.54 $82,438 - $100,009	2,737 Added 4.13%	69,067 $2.26 Million
Q1 2020 May 06, 2020	BUY	$27.03 - $38.62 $21,461 - $30,664	794 Added 1.21%	66,330 $2.17 Million
Q4 2019 Jan 21, 2020	BUY	$32.92 - $37.36 $17,184 - $19,501	522 Added 0.8%	65,536 $2.57 Million
Q3 2019 Nov 06, 2019	SELL	$32.49 - $42.13 $17,382 - $22,539	-535 Reduced 0.82%	65,014 $2.34 Million
Q2 2019 Jul 19, 2019	SELL	$36.98 - $41.52 $5,029 - $5,646	-136 Reduced 0.21%	65,549 $2.84 Million
Q1 2019 May 03, 2019	SELL	$37.5 - $41.2 $51,337 - $56,402	-1,369 Reduced 2.04%	65,685 $2.79 Million
Q4 2018 Jan 30, 2019	SELL	$38.47 - $43.86 $643,449 - $733,602	-16,726 Reduced 19.96%	67,054 $2.93 Million
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $1.78 Million - $2.16 Million	51,644 Added 160.7%	83,780 $3.69 Million
Q2 2018 Aug 15, 2018	SELL	$32.98 - $35.16 $91,651 - $97,709	-2,779 Reduced 7.96%	32,136 $1.17 Million
Q1 2018 May 07, 2018	BUY	$31.91 - $37.02 $124,576 - $144,526	3,904 Added 12.59%	34,915 $1.24 Million
Q4 2017 Feb 13, 2018	BUY	$33.26 - $35.29 $9,811 - $10,410	295 Added 0.96%	31,011 $1.12 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $13,361 - $14,718	431 Added 1.42%	30,716 $1.1 Million
Q2 2017 Aug 14, 2017	BUY	N/A	30,285	30,285 $1.02 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Focused Wealth Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Focused Wealth Management, Inc with notifications on news.

Account

Focused Wealth Management, Inc Pfizer Inc Transaction History